ARticles et affiches

• Metabolic Effects of Tesamorelin, a Growth Hormone-Releasing Factor Analogue, in HIV-infected Patients with Excess Abdominal Fat. A Pooled Analysis of 2 Phase 3 Trials. (PDF : 144,62 K)

  11 novembre 2009

• Pharmacokinetic/Pharmacodynamic Evaluation of Tesamorelin (TH9507), a Growth Hormone-Releasing Factor (GRF) Analog, Administered Subcutaneously Once Daily for 14 Consecutive Days in Healthy and HIV Positive Populations (PDF : 126,37 K)

  12 juin 2009

• Impact of Tesamorelin (TH9507), a Stabilized Growth Hormone-Releasing Factor (GRF) Analogue, on the Pharmacokinetics of Simvastatin and Ritonavir in Healthy Volunteers (PDF : 45,70 K)

  27 avril 2009

• Atherogenic Lipid Profile in Treated HIV Patients with Increased Visceral Adiposity:Association with More Severe CVD Risk Parameters and Response to Tesamorelin (TH9507), a Growth Hormone-Releasing Factor (GRF) Analogue (PDF : 128,71 K)

  9 février 2009